Trials Define Anti-Tumor Effects of Anti-Resorptive Agents.
- Published in:
- BioDrugs, 2011, v. 25, n. 2, p. 135, doi. 10.2165/11590730-000000000-00000
- Publication type:
- Article
Works matching IS 11738804 AND DT 2011 AND VI 25 AND IP 2
Results: 7
1
2
Spotlight on Cetuximab in Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- BioDrugs, 2011, v. 25, n. 2, p. 129, doi. 10.2165/11207030-000000000-00000
- Publication type:
- Article
3
Evaluation of Process Efficiency and Bioequivalence of Biosimilar Recombinant Human Chorionic Gonadotropin (rhCG).
- Published in:
- BioDrugs, 2011, v. 25, n. 2, p. 115, doi. 10.2165/11589430-000000000-00000
- Publication type:
- Article
4
Recombinant Drug Development, Regulation, and Commercialization.
- Published in:
- BioDrugs, 2011, v. 25, n. 2, p. 105, doi. 10.2165/11584670-000000000-00000
- Publication type:
- Article
5
Tacrolimus in the Treatment of Ocular Diseases.
- Published in:
- BioDrugs, 2011, v. 25, n. 2, p. 89, doi. 10.2165/11587010-000000000-00000
- Publication type:
- Article
6
Current Status and Future Directions of Gene and Cell Therapy for Cystic Fibrosis.
- Published in:
- BioDrugs, 2011, v. 25, n. 2, p. 77, doi. 10.2165/11586960-000000000-00000
- Publication type:
- Article
7
Crotalidae Polyvalent Immune Fab.
- Published in:
- BioDrugs, 2011, v. 25, n. 2, p. 69, doi. 10.2165/11207250-000000000-00000
- Publication type:
- Article